KalVista Pharmaceuticals, Inc. KALV | $74.12M | 14.81 | 6.25M | +52.7% | +$25.58M | 3.6 | |
Apogee Therapeutics, Inc. APGE | $564.38M | 14.53 | 8.49M | 0% | +$0 | 27.41 | |
Mersana Therapeutics, Inc. MRSN | $50.75M | 9.26 | 11.33M | 0% | +$0 | 2.47 | |
Enliven Therapeutics, Inc. ELVN | $70.82M | 8.56 | 4.03M | +36.26% | +$18.85M | 3.44 | |
4D Molecular Therapeutics, Inc. FDMT | $140.18M | 8.51 | 4.4M | +28.5% | +$31.09M | 6.81 | |
Ocular Therapeutix, Inc. OCUL | $116.14M | 8.24 | 12.76M | +64.13% | +$45.38M | 5.64 | |
Applied Therapeutics, Inc. APLT | $61.71M | 7.94 | 9.07M | +45.2% | +$19.21M | 3 | |
Adverum Biotechnologies, Inc. ADVM | $22.01M | 7.5 | 1.56M | -69.76% | -$50.78M | 1.07 | |
Dianthus Therapeutics, Inc. DNTH | $62.83M | 7.14 | 2.09M | +125.76% | +$35M | 3.05 | |
Astria Therapeutics, Inc. ATXS | $50.79M | 6.57 | 3.61M | +11.87% | +$5.39M | 2.47 | |
ORIC Pharmaceuticals, Inc. ORIC | $60.42M | 6.52 | 4.39M | +80.97% | +$27.03M | 2.94 | |
Pharvaris N.V. PHVS | $78.47M | 6.31 | 3.4M | 0% | +$0 | 3.81 | |
Aquestive Therapeutics, Inc. AQST | $23.67M | 6.1 | 5.56M | New | +$23.67M | 1.15 | |
Viridian Therapeutics, Inc. VRDN | $67.99M | 6.08 | 3.88M | +<0.01% | +$840.48 | 3.3 | |
Spyre Therapeutics, Inc. SYRE | $82.38M | 5.39 | 2.17M | -8.47% | -$7.62M | 4 | |
Cogent Biosciences, Inc. COGT | $34.47M | 5.36 | 5.13M | +9.5% | +$2.99M | 1.67 | |
Terns Pharmaceuticals, Inc. TERN | $22.37M | 5.27 | 3.41M | -24.17% | -$7.13M | 1.09 | |
Trevi Therapeutics, Inc. TRVI | $11.81M | 4.86 | 3.42M | +<0.01% | +$959.10 | 0.57 | |
Taysha Gene Therapies, Inc. TSHA | $25.83M | 4.81 | 9M | -13.57% | -$4.05M | 1.26 | |
Lyra Therapeutics, Inc. LYRA | $16.02M | 4.23 | 2.58M | +0.02% | +$3,110.00 | 0.78 | |
HilleVax, Inc. HLVX | $34.51M | 4.17 | 2.08M | 0% | +$0 | 1.68 | |
Praxis Precision Medicines, Inc. PRAX | $43.09M | 4.13 | 706,126 | +99.68% | +$21.51M | 2.09 | |
Century Therapeutics, Inc. IPSC | $14.23M | 4.09 | 3.41M | New | +$14.23M | 0.69 | |
Cabaletta Bio, Inc. CABA | $26.68M | 3.24 | 1.56M | -39% | -$17.06M | 1.3 | |
Celcuity Inc. CELC | $20.95M | 3.11 | 970,000 | -48.56% | -$19.78M | 1.02 | |
Merus N.V. MRUS | $80.61M | 3.05 | 1.79M | -16.66% | -$16.12M | 3.92 | |
Dyne Therapeutics, Inc. DYN | $61.72M | 2.23 | 2.17M | 0% | +$0 | 3 | |
Tenaya Therapeutics, Inc. TNYA | $8.14M | 1.98 | 1.56M | New | +$8.14M | 0.4 | |
Edgewise Therapeutics, Inc. EWTX | $33.16M | 1.95 | 1.82M | New | +$33.16M | 1.61 | |
Immatics N.V. IMTX | $18.39M | 1.7 | 1.75M | New | +$18.39M | 0.89 | |
Mineralys Therapeutics, Inc. MLYS | $7.17M | 1.12 | 555,554 | New | +$7.17M | 0.35 | |
Acelyrin, Inc. SLRN | $6.33M | 0.95 | 937,113 | 0% | +$0 | 0.31 | |
Arvinas, Inc. ARVN | $25.92M | 0.92 | 627,788 | 0% | +$0 | 1.26 | |
CG Oncology, Inc. Common stock CGON | $15.37M | 0.53 | 350,000 | New | +$15.37M | 0.75 | |
EyePoint Pharmaceuticals, Inc. EYPT | $5.17M | 0.48 | 250,000 | 0% | +$0 | 0.25 | |
Olema Pharmaceuticals, Inc. OLMA | $872,115.00 | 0.14 | 77,042 | 0% | +$0 | 0.04 | |
Abivax SA American Depositary Shares ABVX | $19.24M | <0.01 | 1.35M | +34.77% | +$4.97M | 0.94 |